ABEV3.SA (ABEV3.SA)

$230.7B
Market Cap
14.9
P/E Ratio
0.28
Beta
16.17%
Dividend Yield
Piotroski 7/9Altman Z 3.6 SafeBeneish M -2.74 CleanROIC−WACC +9.6%

Quantitative Summary

Deterministic

Financial health metrics are strong: Piotroski 7/9, Altman Z 3.6 (above 3.0 safe zone threshold).

Generated deterministically from quant metrics and financial statements. Not a recommendation.

Algorithmic Teardown

AI-Generated

The capital allocation profile demonstrates robust economic moats, evidenced by a ROIC of 17.6% significantly outpacing the cost of equity at an 8.0% WACC to generate a +9.6% spread. This efficiency is underpinned by DuPont decomposition where high gross margins of 51.4% and net margins of 17.6% drive returns, though revenue contraction of -1.4% suggests margin preservation amidst shrinking top-line volume rather than expansion-driven growth. Financial integrity metrics reinforce this stability; a Piotroski F-Score of 7/9 indicates strong fundamental quality with only minor deterioration in financial health, while an Altman Z-Score of 3.6 places the entity safely within the safe zone for bankruptcy risk and a Beneish M-Score of -2.74 signals low probability of earnings manipulation.

Valuation metrics present a divergence between current market pricing and intrinsic value models. The stock trades at a P/E multiple of 14.9x, which requires contextual comparison against sector peers to determine relative cheapness or premium status absent that specific benchmark data. However, the DCF model assigns a fair value of $41, implying that the market may be discounting future cash flows more aggressively than the underlying fundamentals justify if current trading levels fall below this threshold. The implied growth rate embedded in the valuation must reconcile with the observed -1.4% revenue decline to understand whether the price reflects temporary cyclical headwinds or a structural shift in demand dynamics.

Risk assessment reveals no immediate distress signals, as the combination of high profitability ratios and low manipulation scores suggests a resilient balance sheet capable of weathering minor market volatility. The absence of provided Fama-French alpha data limits insight into style-based outperformance relative to size and value factors, while insider activity details are unavailable for sentiment analysis. Ultimately, the risk/reward profile hinges on whether the -1.4% revenue trend reverses or stabilizes; if top-line growth normalizes without eroding the substantial margin cushion, the current valuation could offer compelling upside potential anchored by the wide ROIC-WACC spread and strong credit metrics.

Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.

DCF Sandbox

Interactive

Sensitivity Matrix

TG ↓ / WACC →6%8%10%
2%$54$36$27
3%$69$41$30
4%$100$50$33

Center = base case. Green = >10% upside, Red = >10% downside vs .

Pre-computed DCF: WACC=8.0%, terminal growth 3%. Fair value $41 (+0.0%). Not investment advice.

Price Chart with Moving Averages

Loading chart...
SMA 50 SMA 200

Quant Health Deep Dive

7/9
Piotroski F-Score
Strong — high operational efficiency and profitability signals
3.6
Altman Z-Score
Safe Zone — above 3.0 threshold per academic model. Thresholds: >3 safe, 1.8–3 grey, <1.8 distress.
-2.74
Beneish M-Score
Below threshold — no statistical earnings quality concern per Beneish model. Threshold: <-2.22 = below threshold.

Profitability & Value Creation

51.4%
Gross Margin
17.6%
Net Margin
17.6%
ROIC
8.0%
WACC
ROIC − WACC Spread: +9.6%— Positive value creation spread.
-1.4%
Revenue Growth (YoY)
+7.4%
Earnings Growth (YoY)
19.9B
Free Cash Flow
103%
FCF Payout Ratio

⚠️ Dividend consumes >80% of FCF — sustainability risk.

Balance Sheet Health

0.63x
Debt / Equity
0.96x
Current Ratio
8.1x
Interest Coverage
-0.6x
Net Debt / EBITDA
9.36%
FCF Yield
29.0B
EBITDA

Earnings Surprise History

Q4
✗ Miss
Est: $0.25
Act: $0.24
-4.1%
Q3
✗ Miss
Est: $0.19
Act: $0.18
-3.3%
Q2
✓ Beat
Est: $0.20
Act: $0.24
+18.2%
Q1
✗ Miss
Est: $0.28
Act: $0.28
-0.7%

EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.

Underwater (Drawdown from Peak)

How far below the all-time high the price has been over time. Deeper = more pain for holders.

Loading drawdown chart...

Rolling 60-Day Beta vs S&P 500 (VOO)

How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.

Loading beta chart...
Rolling Beta Market (β = 1.0)

Fundamentals

13.2
Forward P/E
PEG Ratio
2.62
Price/Book
28M
Avg Volume
$16.77
52W High
$11.68
52W Low
52W Range Position

ABEV3.SA Capital Efficiency

How efficiently does ABEV3.SA convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.

Free Cash Flow
$19.9B
EBITDA
$29.0B
FCF Conversion
69%
Reinvestment Rate
31%
69% of EBITDA → Free Cash
0% (cash burn)25% (low)50% (efficient)100% (pure cash)
ROIC
17.6%
ROIC − WACC Spread
9.6%

ABEV3.SA converts 69% of its EBITDA into free cash flow, an exceptional conversion rate indicating an asset-light business model with minimal capital reinvestment drag. The positive ROIC-WACC spread of 9.6% confirms that reinvested capital creates shareholder value.

Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.

Compare ABEV3.SA to Peers

Quant metrics computed deterministically from financial statements and price data. Updated: N/A.

SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.